Arrowhead Pharmaceuticals Inc. buy B. Riley
Start price
12.08.24
/
50%
€21.28
Target price
12.08.25
€50.31
Performance (%)
-33.18%
Price
06.08.25
€14.00
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by B__Riley for Arrowhead Pharmaceuticals Inc. is performing very badly with a performance of -33.18%. This prediction currently runs until 12.08.25. The prediction end date can be changed by B__Riley at any time. B__Riley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 3.266% | 3.266% |
| iShares Core DAX® | -1.351% | 0.610% |
| iShares Nasdaq 100 | -1.453% | 3.019% |
| iShares Nikkei 225® | -0.021% | 1.195% |
| iShares S&P 500 | -1.326% | 2.830% |
Comments by B__Riley for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $55.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by B__Riley for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€18.85
14.02.25
14.02.25
€36.16
14.02.26
14.02.26
-25.76%
06.08.25
06.08.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€31.22
20.07.23
20.07.23
€49.32
20.07.24
20.07.24
-17.26%
21.07.24
21.07.24